The use of telemedicine in Italian Blood Banks: a nationwide survey
Identifieur interne : 000851 ( Ncbi/Merge ); précédent : 000850; suivant : 000852The use of telemedicine in Italian Blood Banks: a nationwide survey
Auteurs : Pierluigi Berti [Italie] ; Franco Verlicchi [Italie] ; Francesco Fiorin [Italie] ; Roberto Guaschino [Italie] ; Adelio Cangemi [Italie]Source :
- Blood Transfusion [ 1723-2007 ] ; 2014.
Abstract
Telemedicine is defined as the use of electronic information and communication technologies to provide health care between distant people. Many activities in transfusion medicine could benefit from the application of telemedicine. To map the spread of the use of telemedicine in transfusion medicine in Italy, the Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) performed a nationwide survey: the results are presented in this paper.
A survey, dealing with different aspects of the use of telemedicine, was performed by sending a questionnaire to 280 Italian Blood Centres. The survey was designed to evaluate the diffusion of telemedicine and the features of the systems, with special attention to the systems’ safety and legal adequacy. One section of the questionnaire was designed to identify the features of the systems considered essential by the respondents.
Out of 280 Blood Services contacted, 196 (70%) filled in at least one of the questions of the online questionnaire. Globally the use of some form of telemedicine was reported by 70% of the respondents. Telemedicine is used for remote validation of laboratory tests by 32% of the Centres that responded, for remote biological validation of blood units by 34% and for assignment of blood components by 29%. Less frequently, telemedicine is used to control electronic refrigerators, for electronic blood requests and for bed-side identification of patients.
The use of telemedicine is widespread in Italian Blood Services. There appears to be some heterogeneity between structures with regards to the evaluation of the systems’ safety and their legal adequacy. No telemedicine system should be introduced into practice until it has proven to have the same standards of safety as the corresponding “on site” activity.
Url:
DOI: 10.2450/2012.0112-12
PubMed: 23149141
PubMed Central: 3934294
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000369
- to stream Pmc, to step Curation: 000369
- to stream Pmc, to step Checkpoint: 000116
Links to Exploration step
PMC:3934294Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The use of telemedicine in Italian Blood Banks: a nationwide survey</title><author><name sortKey="Berti, Pierluigi" sort="Berti, Pierluigi" uniqKey="Berti P" first="Pierluigi" last="Berti">Pierluigi Berti</name><affiliation wicri:level="1"><nlm:aff id="af1-blt-12-s131">Immunohaematology and Transfusion Service, Aosta, Italy</nlm:aff><country xml:lang="fr">Italie</country><wicri:regionArea>Immunohaematology and Transfusion Service, Aosta</wicri:regionArea><wicri:noRegion>Aosta</wicri:noRegion></affiliation></author><author><name sortKey="Verlicchi, Franco" sort="Verlicchi, Franco" uniqKey="Verlicchi F" first="Franco" last="Verlicchi">Franco Verlicchi</name><affiliation wicri:level="1"><nlm:aff id="af2-blt-12-s131">Transfusion Service, Department of Clinical Pathology and Transfusion Medicine, Ravenna, Italy</nlm:aff><country xml:lang="fr">Italie</country><wicri:regionArea>Transfusion Service, Department of Clinical Pathology and Transfusion Medicine, Ravenna</wicri:regionArea><wicri:noRegion>Ravenna</wicri:noRegion></affiliation></author><author><name sortKey="Fiorin, Francesco" sort="Fiorin, Francesco" uniqKey="Fiorin F" first="Francesco" last="Fiorin">Francesco Fiorin</name><affiliation wicri:level="1"><nlm:aff id="af3-blt-12-s131">Transfusion Service, San Donà di Piave, Italy</nlm:aff><country xml:lang="fr">Italie</country><wicri:regionArea>Transfusion Service, San Donà di Piave</wicri:regionArea><wicri:noRegion>San Donà di Piave</wicri:noRegion></affiliation></author><author><name sortKey="Guaschino, Roberto" sort="Guaschino, Roberto" uniqKey="Guaschino R" first="Roberto" last="Guaschino">Roberto Guaschino</name><affiliation wicri:level="1"><nlm:aff id="af4-blt-12-s131">Immunohaematology and Transfusion Service, Alessandria, Italy</nlm:aff><country xml:lang="fr">Italie</country><wicri:regionArea>Immunohaematology and Transfusion Service, Alessandria</wicri:regionArea><wicri:noRegion>Alessandria</wicri:noRegion></affiliation></author><author><name sortKey="Cangemi, Adelio" sort="Cangemi, Adelio" uniqKey="Cangemi A" first="Adelio" last="Cangemi">Adelio Cangemi</name><affiliation wicri:level="1"><nlm:aff id="af5-blt-12-s131">Immunohaematology and Transfusion Service, Varese, Italy</nlm:aff><country xml:lang="fr">Italie</country><wicri:regionArea>Immunohaematology and Transfusion Service, Varese</wicri:regionArea><wicri:noRegion>Varese</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">23149141</idno><idno type="pmc">3934294</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934294</idno><idno type="RBID">PMC:3934294</idno><idno type="doi">10.2450/2012.0112-12</idno><date when="2014">2014</date><idno type="wicri:Area/Pmc/Corpus">000369</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000369</idno><idno type="wicri:Area/Pmc/Curation">000369</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000369</idno><idno type="wicri:Area/Pmc/Checkpoint">000116</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000116</idno><idno type="wicri:Area/Ncbi/Merge">000851</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">The use of telemedicine in Italian Blood Banks: a nationwide survey</title><author><name sortKey="Berti, Pierluigi" sort="Berti, Pierluigi" uniqKey="Berti P" first="Pierluigi" last="Berti">Pierluigi Berti</name><affiliation wicri:level="1"><nlm:aff id="af1-blt-12-s131">Immunohaematology and Transfusion Service, Aosta, Italy</nlm:aff><country xml:lang="fr">Italie</country><wicri:regionArea>Immunohaematology and Transfusion Service, Aosta</wicri:regionArea><wicri:noRegion>Aosta</wicri:noRegion></affiliation></author><author><name sortKey="Verlicchi, Franco" sort="Verlicchi, Franco" uniqKey="Verlicchi F" first="Franco" last="Verlicchi">Franco Verlicchi</name><affiliation wicri:level="1"><nlm:aff id="af2-blt-12-s131">Transfusion Service, Department of Clinical Pathology and Transfusion Medicine, Ravenna, Italy</nlm:aff><country xml:lang="fr">Italie</country><wicri:regionArea>Transfusion Service, Department of Clinical Pathology and Transfusion Medicine, Ravenna</wicri:regionArea><wicri:noRegion>Ravenna</wicri:noRegion></affiliation></author><author><name sortKey="Fiorin, Francesco" sort="Fiorin, Francesco" uniqKey="Fiorin F" first="Francesco" last="Fiorin">Francesco Fiorin</name><affiliation wicri:level="1"><nlm:aff id="af3-blt-12-s131">Transfusion Service, San Donà di Piave, Italy</nlm:aff><country xml:lang="fr">Italie</country><wicri:regionArea>Transfusion Service, San Donà di Piave</wicri:regionArea><wicri:noRegion>San Donà di Piave</wicri:noRegion></affiliation></author><author><name sortKey="Guaschino, Roberto" sort="Guaschino, Roberto" uniqKey="Guaschino R" first="Roberto" last="Guaschino">Roberto Guaschino</name><affiliation wicri:level="1"><nlm:aff id="af4-blt-12-s131">Immunohaematology and Transfusion Service, Alessandria, Italy</nlm:aff><country xml:lang="fr">Italie</country><wicri:regionArea>Immunohaematology and Transfusion Service, Alessandria</wicri:regionArea><wicri:noRegion>Alessandria</wicri:noRegion></affiliation></author><author><name sortKey="Cangemi, Adelio" sort="Cangemi, Adelio" uniqKey="Cangemi A" first="Adelio" last="Cangemi">Adelio Cangemi</name><affiliation wicri:level="1"><nlm:aff id="af5-blt-12-s131">Immunohaematology and Transfusion Service, Varese, Italy</nlm:aff><country xml:lang="fr">Italie</country><wicri:regionArea>Immunohaematology and Transfusion Service, Varese</wicri:regionArea><wicri:noRegion>Varese</wicri:noRegion></affiliation></author></analytic><series><title level="j">Blood Transfusion</title><idno type="ISSN">1723-2007</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Background</title><p>Telemedicine is defined as the use of electronic information and communication technologies to provide health care between distant people. Many activities in transfusion medicine could benefit from the application of telemedicine. To map the spread of the use of telemedicine in transfusion medicine in Italy, the Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) performed a nationwide survey: the results are presented in this paper.</p></sec><sec><title>Materials and methods</title><p>A survey, dealing with different aspects of the use of telemedicine, was performed by sending a questionnaire to 280 Italian Blood Centres. The survey was designed to evaluate the diffusion of telemedicine and the features of the systems, with special attention to the systems’ safety and legal adequacy. One section of the questionnaire was designed to identify the features of the systems considered essential by the respondents.</p></sec><sec><title>Results</title><p>Out of 280 Blood Services contacted, 196 (70%) filled in at least one of the questions of the online questionnaire. Globally the use of some form of telemedicine was reported by 70% of the respondents. Telemedicine is used for remote validation of laboratory tests by 32% of the Centres that responded, for remote biological validation of blood units by 34% and for assignment of blood components by 29%. Less frequently, telemedicine is used to control electronic refrigerators, for electronic blood requests and for bed-side identification of patients.</p></sec><sec><title>Discussion</title><p>The use of telemedicine is widespread in Italian Blood Services. There appears to be some heterogeneity between structures with regards to the evaluation of the systems’ safety and their legal adequacy. No telemedicine system should be introduced into practice until it has proven to have the same standards of safety as the corresponding “on site” activity.</p></sec></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Blood Transfus</journal-id><journal-id journal-id-type="iso-abbrev">Blood Transfus</journal-id><journal-id journal-id-type="publisher-id">SIMTI</journal-id><journal-title-group><journal-title>Blood Transfusion</journal-title></journal-title-group><issn pub-type="ppub">1723-2007</issn><publisher><publisher-name>Edizioni SIMTI - SIMTI Servizi Srl</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23149141</article-id><article-id pub-id-type="pmc">3934294</article-id><article-id pub-id-type="doi">10.2450/2012.0112-12</article-id><article-id pub-id-type="publisher-id">blt-12-s131</article-id><article-categories><subj-group subj-group-type="heading"><subject>Transfusion Medicine and Transfusion Complications</subject><subj-group><subject>Original Articles</subject></subj-group></subj-group></article-categories><title-group><article-title>The use of telemedicine in Italian Blood Banks: a nationwide survey</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Berti</surname><given-names>Pierluigi</given-names></name><xref ref-type="aff" rid="af1-blt-12-s131">1</xref><xref ref-type="corresp" rid="c1-blt-12-s131"></xref></contrib><contrib contrib-type="author"><name><surname>Verlicchi</surname><given-names>Franco</given-names></name><xref ref-type="aff" rid="af2-blt-12-s131">2</xref></contrib><contrib contrib-type="author"><name><surname>Fiorin</surname><given-names>Francesco</given-names></name><xref ref-type="aff" rid="af3-blt-12-s131">3</xref></contrib><contrib contrib-type="author"><name><surname>Guaschino</surname><given-names>Roberto</given-names></name><xref ref-type="aff" rid="af4-blt-12-s131">4</xref></contrib><contrib contrib-type="author"><name><surname>Cangemi</surname><given-names>Adelio</given-names></name><xref ref-type="aff" rid="af5-blt-12-s131">5</xref></contrib></contrib-group><aff id="af1-blt-12-s131"><label>1</label>Immunohaematology and Transfusion Service, Aosta, Italy</aff><aff id="af2-blt-12-s131"><label>2</label>Transfusion Service, Department of Clinical Pathology and Transfusion Medicine, Ravenna, Italy</aff><aff id="af3-blt-12-s131"><label>3</label>Transfusion Service, San Donà di Piave, Italy</aff><aff id="af4-blt-12-s131"><label>4</label>Immunohaematology and Transfusion Service, Alessandria, Italy</aff><aff id="af5-blt-12-s131"><label>5</label>Immunohaematology and Transfusion Service, Varese, Italy</aff><author-notes><corresp id="c1-blt-12-s131">Correspondence: Pierluigi Berti, Immunohematology and Transfusion Medicine, Azienda USL Valle d’Aosta, “U. Parini” Regional Hospital, Viale Ginevra 3, 11100 Aosta, Italy, e-mail: <email>pberti@ausl.vda.it</email></corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2014</year></pub-date><volume>12</volume><issue>Suppl 1</issue><fpage>s131</fpage><lpage>s136</lpage><history><date date-type="received"><day>04</day><month>6</month><year>2012</year></date><date date-type="accepted"><day>10</day><month>9</month><year>2012</year></date></history><permissions><copyright-statement>© SIMTI Servizi Srl</copyright-statement><copyright-year>2014</copyright-year></permissions><abstract><sec><title>Background</title><p>Telemedicine is defined as the use of electronic information and communication technologies to provide health care between distant people. Many activities in transfusion medicine could benefit from the application of telemedicine. To map the spread of the use of telemedicine in transfusion medicine in Italy, the Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) performed a nationwide survey: the results are presented in this paper.</p></sec><sec><title>Materials and methods</title><p>A survey, dealing with different aspects of the use of telemedicine, was performed by sending a questionnaire to 280 Italian Blood Centres. The survey was designed to evaluate the diffusion of telemedicine and the features of the systems, with special attention to the systems’ safety and legal adequacy. One section of the questionnaire was designed to identify the features of the systems considered essential by the respondents.</p></sec><sec><title>Results</title><p>Out of 280 Blood Services contacted, 196 (70%) filled in at least one of the questions of the online questionnaire. Globally the use of some form of telemedicine was reported by 70% of the respondents. Telemedicine is used for remote validation of laboratory tests by 32% of the Centres that responded, for remote biological validation of blood units by 34% and for assignment of blood components by 29%. Less frequently, telemedicine is used to control electronic refrigerators, for electronic blood requests and for bed-side identification of patients.</p></sec><sec><title>Discussion</title><p>The use of telemedicine is widespread in Italian Blood Services. There appears to be some heterogeneity between structures with regards to the evaluation of the systems’ safety and their legal adequacy. No telemedicine system should be introduced into practice until it has proven to have the same standards of safety as the corresponding “on site” activity.</p></sec></abstract><kwd-group><kwd>telemedicine</kwd><kwd>blood transfusion</kwd><kwd>survey</kwd><kwd>questionnaire</kwd></kwd-group></article-meta></front></pmc><affiliations><list><country><li>Italie</li></country></list><tree><country name="Italie"><noRegion><name sortKey="Berti, Pierluigi" sort="Berti, Pierluigi" uniqKey="Berti P" first="Pierluigi" last="Berti">Pierluigi Berti</name></noRegion><name sortKey="Cangemi, Adelio" sort="Cangemi, Adelio" uniqKey="Cangemi A" first="Adelio" last="Cangemi">Adelio Cangemi</name><name sortKey="Fiorin, Francesco" sort="Fiorin, Francesco" uniqKey="Fiorin F" first="Francesco" last="Fiorin">Francesco Fiorin</name><name sortKey="Guaschino, Roberto" sort="Guaschino, Roberto" uniqKey="Guaschino R" first="Roberto" last="Guaschino">Roberto Guaschino</name><name sortKey="Verlicchi, Franco" sort="Verlicchi, Franco" uniqKey="Verlicchi F" first="Franco" last="Verlicchi">Franco Verlicchi</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/TelematiV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000851 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000851 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Ticri/CIDE
|area= TelematiV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= PMC:3934294
|texte= The use of telemedicine in Italian Blood Banks: a nationwide survey
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:23149141" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a TelematiV1
| This area was generated with Dilib version V0.6.31. |  |